Authors:
CUFER T
LAZAREV A
ELGHAMRAWY K
DOVAL D
VRBA Z
SHAH P
KURTOVA A
GHILEZAN N
CHALOFTI I
BLANC C
Citation: T. Cufer et al., PRELIMINARY DATA OF A PHASE-II TRIAL OF TAXOTERE (TXT) 100 OR 75 MG M(2) AS 2ND LINE CHEMOTHERAPY (CT) IN PATIENTS (PTS) WITH METASTATIC BREAST-CANCER (MBC) WITH STRATIFICATION ACCORDING TO PROGNOSIS FACTORS/, Annals of oncology, 9, 1998, pp. 78-78
Authors:
HONIG PK
WORTHAM DC
LAZAREV A
CANTILENA LR
Citation: Pk. Honig et al., GRAPEFRUIT JUICE ALTERS THE SYSTEMIC BIOAVAILABILITY AND CARDIAC REPOLARIZATION OF TERFENADINE IN POOR METABOLIZERS OF TERFENADINE, Journal of clinical pharmacology, 36(4), 1996, pp. 345-351
Authors:
LEVINE M
CONRYCANTILENA C
WANG YH
WELCH RW
WASHKO PW
DHARIWAL KR
PARK JB
LAZAREV A
GRAUMLICH JF
KING J
CANTILENA LR
Citation: M. Levine et al., VITAMIN-C PHARMACOKINETICS IN HEALTHY-VOLUNTEERS - EVIDENCE FOR A RECOMMENDED DIETARY ALLOWANCE, Proceedings of the National Academy of Sciences of the United Statesof America, 93(8), 1996, pp. 3704-3709
Citation: A. Lazarev et M. Movshev, ON THE COHOMOLOGY AND DEFORMATIONS OF DIFFERENTIAL GRADED ALGEBRAS, Journal of pure and applied algebra, 106(2), 1996, pp. 141-151
Authors:
LAZAREV A
SHOIKHET J
PETROVA V
SHIKHMAN S
Citation: A. Lazarev et al., THE CANCER-EPIDEMIOLOGY IN REGION SUBJECTED TO MULTIPLE RADIATION INFLUENCE, European journal of cancer, 31A, 1995, pp. 167-167
Authors:
LEHAR F
ADIASEVICH B
ANDROSOV VP
ANGELOV N
ANISCHENKO N
ANTONENKO V
BALL J
BARYSHEVSKY VG
BAZHANOV NA
BELYAEV AA
BENDA B
BODYAGIN V
BORISOV N
BORZUNOV Y
BRADAMANTE F
BUNYATOVA E
BURINOV V
CHERNYKH E
COMBET M
DATSKOV A
DURAND G
DZYUBAK AP
FONTAINE JM
GETMAN VA
GIORGI M
GOLOVANOV L
GREBENYUK V
GROSNICK D
GUREVICH G
HASEGAWA T
HILL D
HORIKAWA N
IGO G
JANOUT Z
KALINNIKOV VA
KARNAUKHOV IM
KASPRZYK T
KHACHATUROV BA
KIRILLOV A
KISSELEV Y
KOUSMINE ES
KOVALENKO A
KOVALJOV AI
LADYGIN VP
LAZAREV A
LECONTE P
DELESQUEN A
LUKHANIN AA
MANGO S
MARTIN A
MATAFONOV VN
MATYUSHEVSKY E
MIRONOV S
NEGANOV AB
NEGANOV BS
NOMOFILOV A
PERELYGIN V
PLIS Y
PILIPENKO Y
PISAREV IL
PISKUNOV N
POLUNIN Y
POPKOV YP
PROPOV AA
PROKOFIEV AN
REKALO MP
RUKOYATKIN P
SANS JL
SAPOZHNIKOV MG
SHAROV V
SHILOV S
SHISHOV Y
SITNIK IM
SOROKIN PV
SPINKA H
SPOROV EA
STRUNOV LN
SVETOV A
DESWART JJ
TELEGIN YP
TOLMASHOV I
TRENTALANGE S
TSVINEV A
USOV YA
VIKHROV VV
WHITTEN CA
ZAPOROZHETS S
ZARUBIN A
ZHDANOV AA
ZOLIN L
Citation: F. Lehar et al., THE MOVABLE POLARIZED TARGET AS A BASIC EQUIPMENT FOR HIGH-ENERGY SPIN PHYSICS EXPERIMENTS AT THE JINR-DUBNA ACCELERATOR COMPLEX, Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment, 356(1), 1995, pp. 58-61
Citation: P. Honig et al., PHARMACOKINETICS AND CARDIAC EFFECTS OF TERFENADINE IN POOR METABOLIZERS RECEIVING CONCOMITANT GRAPEFRUIT JUICE, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 185-185
Citation: Ty. Kuang et al., COMPARISON OF HUMAN LIVER SLICES TO HUMAN LIVER-MICROSOMES AS POTENTIAL SCREENING SYSTEMS FOR TERFENADINE DRUG-INTERACTIONS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 138-138
Citation: Ty. Kuang et al., HUMAN CYP3A4 AS A POTENTIAL IN-VITRO SCREENING SYSTEM FOR TERFENADINEDRUG-INTERACTIONS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 139-139
Authors:
GRAUMLICH JF
LUDDEN TM
CANTILENA CC
LEVINE M
WELCH RW
WANG Y
DHARIWAL K
PARK J
WASHKO P
LAZAREV A
KING J
CANTILENA LR
Citation: Jf. Graumlich et al., PHARMACOKINETIC MODEL OF ASCORBIC-ACID IN DEPLETION AND REPLETION, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 200-200